Q3 EPS Estimates for Henry Schein Reduced by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Leerink Partnrs dropped their Q3 2025 earnings estimates for Henry Schein in a research note issued on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings per share of $1.20 for the quarter, down from their prior forecast of $1.26. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s FY2026 earnings at $4.96 EPS and FY2027 earnings at $5.48 EPS.

Other analysts also recently issued reports about the stock. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. StockNews.com raised Henry Schein from a “hold” rating to a “buy” rating in a research report on Wednesday, April 9th. Finally, UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Five equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Trading Down 2.0 %

NASDAQ HSIC opened at $64.28 on Monday. Henry Schein has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock’s 50 day moving average price is $71.27 and its two-hundred day moving average price is $72.13. The stock has a market capitalization of $7.98 billion, a price-to-earnings ratio of 26.45, a PEG ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.66 EPS.

Insider Activity at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Henry Schein

Several large investors have recently modified their holdings of HSIC. Versant Capital Management Inc boosted its holdings in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares during the period. Investment Management Corp VA ADV acquired a new stake in Henry Schein during the fourth quarter worth approximately $32,000. Venturi Wealth Management LLC boosted its holdings in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC grew its position in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares during the last quarter. Finally, Smartleaf Asset Management LLC increased its stake in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the period. 96.62% of the stock is owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.